Healthcare provider profile · identity verified

James Robert Barton, MD

Allopathic & Osteopathic Physicians|Internal Medicine · JASPER, AL · NPI 1275567182

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show James Robert Barton, MD received $81.72 in general payments during 2025 across 4 reported records.

PFIZER INC. accounted for 58.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 70 claims for Trelegy Ellipta by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 251 claims for Eliquis by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$81.72

4 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
PFIZER INC.	Unresolved — no canonical attribution shown	$47.45	58.1%	2	2025
GlaxoSmithKline, LLC.	Unresolved — no canonical attribution shown	$17.51	21.4%	1	2025
Octapharma USA, Inc.	Unresolved — no canonical attribution shown	$16.76	20.5%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$81.72	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
ELREXFIO Normalized: elrexfio	Drug	PFIZER INC.	$47.45	2	2025
Source payment records 2025-07-22 · PFIZER INC. · $25.55 · Open Payments source 2025-11-20 · PFIZER INC. · $21.90 · Open Payments source
ADCETRIS Normalized: adcetris	Biological	PFIZER INC.	$25.55	1	2025
Source payment records 2025-07-22 · PFIZER INC. · $25.55 · Open Payments source
TRELEGY ELLIPTA Normalized: trelegy ellipta	Drug	GlaxoSmithKline, LLC.	$17.51	1	2025
Source payment records 2025-02-10 · GlaxoSmithKline, LLC. · $17.51 · Open Payments source
OCTAGAM IMMUNE GLOBULIN (HUMAN) Normalized: octagam immune globulin human	Biological	Octapharma USA, Inc.	$16.76	1	2025
Source payment records 2025-07-01 · Octapharma USA, Inc. · $16.76 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
TRELEGY ELLIPTA trelegy ellipta	2025	Trelegy Ellipta	2024	70	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	TRELEGY ELLIPTA open payments reported associated product	CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369	Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row	70	20
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063	Eliquis · 2024 Exact normalized brand match · 1 Part D row	251	40

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	614	156
Pantoprazole Sodium	Pantoprazole Sodium	519	125
Rosuvastatin Calcium	Rosuvastatin Calcium	511	114
Metoprolol Succinate	Metoprolol Succinate	499	118
Levothyroxine Sodium	Levothyroxine Sodium	466	100
Amlodipine Besylate	Amlodipine Besylate	409	101
Famotidine	Famotidine	406	102
Omeprazole	Omeprazole	367	88
Duloxetine Hcl	Duloxetine Hcl	362	82
Potassium Chloride	Potassium Chloride	347	90
Lisinopril	Lisinopril	346	80
Albuterol Sulfate Hfa	Albuterol Sulfate	326	103
Losartan Potassium	Losartan Potassium	326	74
Tamsulosin Hcl	Tamsulosin Hcl	295	75
Furosemide	Furosemide	263	71
Eliquis	Apixaban	251	40
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	248	76
Tizanidine Hcl	Tizanidine Hcl	241	69
Ezetimibe	Ezetimibe	216	52
Tramadol Hcl	Tramadol Hcl	204	44
Esomeprazole Magnesium	Esomeprazole Magnesium	198	43
Gabapentin	Gabapentin	198	50
Cefdinir	Cefdinir	175	118
Glimepiride	Glimepiride	175	48
Fluticasone Propionate	Fluticasone Propionate	173	58
Ramipril	Ramipril	158	44
Simvastatin	Simvastatin	157	40
Carvedilol	Carvedilol	153	40
Alprazolam	Alprazolam	151	18
Metoprolol Tartrate	Metoprolol Tartrate	137	36
Ozempic	Semaglutide	131	33
Meloxicam	Meloxicam	127	38
Montelukast Sodium	Montelukast Sodium	125	32
Celecoxib	Celecoxib	124	33
Methylprednisolone	Methylprednisolone	118	76
Nitroglycerin	Nitroglycerin	117	51
Donepezil Hcl	Donepezil Hcl	113	26
Trazodone Hcl	Trazodone Hcl	113	29
Clopidogrel	Clopidogrel Bisulfate	112	30
Pioglitazone Hcl	Pioglitazone Hcl	111	25
Jardiance	Empagliflozin	109	31
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	104	26
Hydrochlorothiazide	Hydrochlorothiazide	101	23
Mirtazapine	Mirtazapine	100	30
Alendronate Sodium	Alendronate Sodium	97	30
Meclizine Hcl	Meclizine Hcl	96	40
Sertraline Hcl	Sertraline Hcl	93	26
Allopurinol	Allopurinol	92	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	91	22
Paroxetine Hcl	Paroxetine Hcl	91	23
Metformin Hcl	Metformin Hcl	84	30
Diclofenac Sodium	Diclofenac Sodium	80	34
Trulicity	Dulaglutide	77	13
Warfarin Sodium	Warfarin Sodium	77	11
Ropinirole Hcl	Ropinirole Hcl	75	15
Dicyclomine Hcl	Dicyclomine Hcl	74	23
Pravastatin Sodium	Pravastatin Sodium	72	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	70	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	20
Finasteride	Finasteride	69	22
Solifenacin Succinate	Solifenacin Succinate	69	20
Benazepril Hcl	Benazepril Hcl	67	14
Buspirone Hcl	Buspirone Hcl	67	15
Linzess	Linaclotide	67	21
Ondansetron Odt	Ondansetron	67	33
Escitalopram Oxalate	Escitalopram Oxalate	65	14
Amitriptyline Hcl	Amitriptyline Hcl	64	16
Oxybutynin Chloride	Oxybutynin Chloride	64	22
Spironolactone	Spironolactone	64	13
Memantine Hcl	Memantine Hcl	61	13
Metoclopramide Hcl	Metoclopramide Hcl	61	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	61	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	58	14
Metformin Hcl Er	Metformin Hcl	58	17
Xarelto	Rivaroxaban	55	11
Ibuprofen	Ibuprofen	54	15
Naproxen	Naproxen	54	17
Bupropion Xl	Bupropion Hcl	53	14
Levofloxacin	Levofloxacin	53	37
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	52	suppressed
Ipratropium Bromide	Ipratropium Bromide	51	26
Fenofibrate	Fenofibrate,micronized	47	suppressed
Januvia	Sitagliptin Phosphate	46	11
Topiramate	Topiramate	46	11
Doxycycline Hyclate	Doxycycline Hyclate	45	40
Prednisone	Prednisone	45	18
Vitamin D2	Ergocalciferol (Vitamin D2)	42	14
Clonidine Hcl	Clonidine Hcl	41	13
Bumetanide	Bumetanide	40	11
Methocarbamol	Methocarbamol	40	17
Testosterone Cypionate	Testosterone Cypionate	40	11
Amiodarone Hcl	Amiodarone Hcl	39	16
Breo Ellipta	Fluticasone/Vilanterol	39	12
Raloxifene Hcl	Raloxifene Hcl	39	suppressed
Aripiprazole	Aripiprazole	38	12
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Clonazepam	Clonazepam	36	suppressed
Estradiol	Estradiol	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	18
Janumet	Sitagliptin Phos/Metformin Hcl	36	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	32
Lorazepam	Lorazepam	35	suppressed
Metronidazole	Metronidazole	35	29
Promethazine Hcl	Promethazine Hcl	35	18
Synthroid	Levothyroxine Sodium	35	suppressed
Nystatin	Nystatin	34	19
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Diazepam	Diazepam	33	suppressed
Farxiga	Dapagliflozin Propanediol	33	suppressed
Propranolol Hcl Er	Propranolol Hcl	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Azithromycin	Azithromycin	32	24
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Victoza 3-Pak	Liraglutide	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Doxepin Hcl	Doxepin Hcl	30	suppressed
Mounjaro	Tirzepatide	29	suppressed
Myrbetriq	Mirabegron	28	suppressed
Sucralfate	Sucralfate	28	suppressed
Ranolazine Er	Ranolazine	27	suppressed
Roflumilast	Roflumilast	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	19
Lacosamide	Lacosamide	25	suppressed
Atenolol	Atenolol	23	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Cilostazol	Cilostazol	22	suppressed
Fluconazole	Fluconazole	22	19
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Dulera	Mometasone/Formoterol	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Mometasone Furoate	Mometasone Furoate	21	suppressed
Risperidone	Risperidone	21	suppressed
Torsemide	Torsemide	21	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Mupirocin	Mupirocin	20	15
Nabumetone	Nabumetone	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Silodosin	Silodosin	20	suppressed
Dexlansoprazole Dr	Dexlansoprazole	19	suppressed
Amoxicillin	Amoxicillin	18	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Livalo	Pitavastatin Calcium	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Temazepam	Temazepam	16	suppressed
Zaleplon	Zaleplon	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Glipizide	Glipizide	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Metolazone	Metolazone	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Calcium Acetate	Calcium Acetate	13	suppressed
Colchicine	Colchicine	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Belsomra	Suvorexant	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Otezla	Apremilast	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Pen Needle	Pen Needle, Diabetic	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Single Use Swab	Alcohol Antiseptic Pads	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$81.72 · 4 records	PFIZER INC.	ADCETRIS, ELREXFIO, OCTAGAM IMMUNE GLOBULIN (HUMAN), TRELEGY ELLIPTA	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error